Where does Ian Peikon work?

Ian Peikon is Venture Partner at Lux Capital.

What check size does Ian Peikon write?

Ian Peikon typically writes checks of $1M – $50M.

Where did Ian Peikon go to school?

Ian Peikon studied at Cold Spring Harbor Laboratory (PhD, Biological Sciences); Duke University (BSE, Biomedical Engineering).

Ian Peikon

Investor

Venture Partner at Lux Capital

New York, New York

Writes $1M – $50M checks · typically $10M

About

Ian Peikon is co-founder and co-chief executive officer of Cajal Therapeutics. He brings experience in team leadership and scientific research, with background in molecular biology, neuroscience, and biomedical engineering.

Experience

Cajal TherapeuticsCo-Founder & Co-Chief Executive Officercurrent2020 — present
Lux CapitalVenture Partnercurrent2019 — presentNew York City Metropolitan Area
Cold Spring Harbor Laboratory Library and ArchivesAdvisory Board Membercurrent2024 — presentCold Spring Harbor, New York, United States
PlexiumBoard Member2022 — 2025
VNV BioCo-Founder & SAB Member2018 — 2022New York City Metropolitan Area
KallyopeCo-Founder & Director, Platform Biology & Technology2015 — 2019

Education

Cold Spring Harbor LaboratoryPhD, Biological Sciences2009 — 2014
Duke UniversityBSE, Biomedical Engineering2005 — 2009

Skills & more

Matlab8C++4C3Python3Molecular Biology19Neuroscience12Biotechnology2Start-ups1Biomedical Engineering10Electrophysiology8Fluorescence Microscopy19Confocal Microscopy16

+12 more

GeneticsCell BiologyComputational BiologyBioinformaticsSynthetic BiologyProtein PurificationWestern BlottingPCREmulsion PCRCell CultureSystems BiologyElectronic Circuit Design

From Ian's professional profile.

Colleagues at Lux Capital

Adam Goulburn

Investor at Lux Capital

Adam Kalish

Partner, Capital Formation at Lux Capital

Ale Salardi

Executive Assistant at Lux Capital

Alex Nguyen

Partner at Lux Capital

Andrew Wilson

Partner, Legal at Lux Capital

Bibi Masara

Office Manager at Lux Capital

Bilal Zuberi

Founder and Managing Partner at Red Glass Ventures

Brad Gritsch

Finance at Lux Capital

Network7

Alex Nguyen

Partner at Lux Capital

Bilal Zuberi

Founder and Managing Partner at Red Glass Ventures

Brandon Reeves

Partner at Lux Capital

Danny Crichton

Partner, Research at Lux Capital, publishing the Securities newsletter and Riskgaming

David Yang

Partner at Lux Capital

Deena Shakir

Partner at Lux Capital

Tess van Stekelenburg

Partner at Lux Capital

Investors connected to Ian in public investor directories — a warm-intro map.

Frequently asked questions

Who is Ian Peikon?: Ian Peikon is co-founder and co-chief executive officer of Cajal Therapeutics. He brings experience in team leadership and scientific research, with background in molecular biology, neuroscience, and biomedical engineering.
Where does Ian Peikon work?: Ian Peikon is Venture Partner at Lux Capital.
What check size does Ian Peikon write?: Ian Peikon typically writes checks of $1M – $50M.
Where did Ian Peikon go to school?: Ian Peikon studied at Cold Spring Harbor Laboratory (PhD, Biological Sciences); Duke University (BSE, Biomedical Engineering).